Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial - Long, G V; Trefzer, U; Davies, M A (Lancet Oncol, 2012)
, et al.